POSTPONED - c4c Multi-Stakeholder Meeting on Child Psychiatry Brussels, Belgium
10.09.20 - 11.09.20
* Due to the recent COVID-19 outbreak the Meeting Programme Committee has decided to postpone the event. The new tentative date has been set on 10-11 September 2020 in Brussels and the date will be confirmed in the coming days.*
Conect4children is glad to inform that the first c4c Multi-Stakeholder Meeting (MSM) will take place on 16-17 April 2020 in Brussels and it will focus on Child Psychiatry.
Conect4children is glad to inform that the first c4c Multi-Stakeholder Meeting (MSM) will take place on 16-17 April 2020 in Brussels and it will focus on Child Psychiatry.
Multi-Stakeholder Meetings have been conceived with the aim to facilitate dialogue and provide an opportunity for constructive interactions between relevant stakeholders on topics requiring open discussion on development of medicines in the best interests of children and adolescents.
The goal of this meeting is to share information, in a pre-competitive setting, to facilitate the developments of innovative medicines and ultimately their introduction into the standard-of-care of children and adolescents with psychiatric disorders.
Outputs
The result of this program will be a potential regulatory pathway for the development of a drug for the treatment of a symptom, with irritability as the example, across child psychiatry disorders. Areas for further research and discussion will also be identified: considering the extensive use of digital devices by children and adolescents, real-time, patient-centered digital measures of outcome will be a secondary topic to be developed.
A white paper will be developed based on these outputs and published.
How to participate
The meeting will be on invitation only. Interested participants can apply by filling the Expression of Interest form available here. Deadline to submit Expression of Interest: 3 March 2020.
Invited participants will be contacted in due time.
Who can participate
Patients/patient representatives, clinicians, academics, pharmaceutical companies and regulators interested in child psychiatry.
Conditions of participation
Participation to the meeting is free of charge.